MicroRNA expression in colorectal cancer

Cancer Biomarkers

Volumn 11, Issue 6, 2012, Pages 239-243

  Hogan, Niamh M ^a   Joyce, Myles R ^a   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 101; MICRORNA 106A; MICRORNA 124A; MICRORNA 125A; MICRORNA 126; MICRORNA 128A; MICRORNA 128B; MICRORNA 133B; MICRORNA 135A; MICRORNA 135B; MICRORNA 137; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 17; MICRORNA 192; MICRORNA 19A; MICRORNA 200C; MICRORNA 21; MICRORNA 25; MICRORNA 29A; MICRORNA 29B; MICRORNA 31; MICRORNA 34A; MICRORNA 9; MICRORNA 92; MICRORNA 95; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; COLORECTAL CANCER; DISEASE MARKER; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSLATION REGULATION; TUMOR MICROENVIRONMENT;

COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871556937     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-00278     Document Type: Article

References (47)

1. Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Sinar DR, et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics. 2009 Sep-Oct; 6(5): 281-95.
2. ArndtGM, Dossey L,Cullen LM,Lai A, Druker R, Eisbacher M, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009; 9: 374.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004 Jan 23; 116(2): 281-97.
4. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003 Apr 4; 113(1): 25-36. (Pubitemid 36411957)
5. Calin GA, Dumitru CD, ShimizuM, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002 Nov 26; 99(24): 15524-9. (Pubitemid 35403967)
6. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Jr., Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci USA. 2006 Mar 7; 103(10): 3687-92. (Pubitemid 43376616)
7. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008; 9: 76.
8. Earle JS, Luthra R, Romans A, Abraham R, Ensor J, Yao H, et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn. 2010 Jul; 12(4): 433-40.
9. Eldh M, Lotvall J, Malmhall C, Ekstrom K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012 Apr; 50(4): 278-86.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. Dec 15; 127(12): 2893-917.
11. Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol. 2007 Mar; 8(3): 245-55. (Pubitemid 46291714)
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006 Jan 1; 34(Database issue): D140-4.
13. Hannon GJ. RNA interference. Nature. 2002 Jul 11; 418 (6894): 244-51. (Pubitemid 34773784)
14. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer. 2002 Jan; 2(1): 38-47. (Pubitemid 37328806)
15. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, KerinMJ. CirculatingmicroRNAs as novelminimally invasive biomarkers for breast cancer. Ann Surg. 2010 Mar; 251(3): 499-505.
16. Heusschen R, van Gink M, Griffioen AW, Thijssen VL. MicroRNAs in the tumor endothelium: novel controls on the angioregulatory switchboard. Biochim Biophys Acta. 2010 Jan; 1805(1): 87-96.
17. Hogan NM, Dwyer RM, Joyce MR, Kerin MJ. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int J Cancer. 2012 Jul 1; 131(1): 1-7.
18. Huang Z, Huang D, Ni S, Peng Z, ShengW, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2011 Jul 1; 127(1): 118-26.
19. KalimuthoM, Di Cecilia S, Del Vecchio Blanco G, Roviello F, Sileri P, Cretella M, et al. Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br J Cancer. 2011 May 24; 104(11): 1770-8.
20. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2002 Oct; 2(10): 727-39. (Pubitemid 37328908)
21. Kucerova L, Altanerova V,Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1; 67(13): 6304-13. (Pubitemid 47037513)
22. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M.AmicroRNA component of the hypoxic response. Cell Death Differ. 2008 Apr; 15(4): 667-71. (Pubitemid 351405070)
23. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. A microRNA signature of hypoxia. Mol Cell Biol. 2007 Mar; 27(5): 1859-67.
24. Kumar S, Mohan A, Guleria R. Biomarkers in cancer screening, research and detection: present and future: a review. Biomarkers. 2006 Sep-Oct; 11(5): 385-405. (Pubitemid 44364079)
25. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993 Dec 3; 75(5): 843-54. (Pubitemid 24014542)
26. Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009 Apr; 33(4): 667-84.
27. Link A, Balaguer F, Shen Y, Nagasaka T, Lozano JJ, Boland CR, et al. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7): 1766-74.
28. Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer. 2012 May 1; 130(9): 2077-87.
29. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003 Oct; 1(12): 882-91. (Pubitemid 37288707)
30. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol. 2009 Apr; 35(4): 339-47.
31. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008 Jul 29; 105(30): 10513-8.
32. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potentialmarker for colorectal cancer screening. Gut. 2009 Oct; 58(10): 1375-81.
33. NugentM,Miller N, Kerin MJ.MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol. 2011 Aug; 37(8): 649-54.
34. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004 Oct 6; 96(19): 1420-5. (Pubitemid 39429665)
35. Pin AL, Houle F, Huot J. Recent advances in colorectal cancer research: the microenvironment impact. Cancer Microenviron. 2011 Aug; 4(2): 127-31.
36. Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2009 Aug; 42(8): 1291-7.
37. Sarver AL, FrenchAJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, et al. Human colon cancer profiles show differential microRNA expression depending onmismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009; 9: 401.
38. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008 Jan 30; 299(4): 425-36. (Pubitemid 351185951)
39. Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 2009 May 7; 15(17): 2089-96.
40. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2007; 72(5-6): 397-402. (Pubitemid 351238155)
41. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009; 8: 102.
42. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology. 2007 Apr; 39(2): 197-207. (Pubitemid 46439650)
43. Waldman SA, Terzic A. TranslatingMicroRNA discovery into clinical biomarkers in cancer. JAMA. 2007 May 2; 297(17): 1923-5. (Pubitemid 46707848)
44. Wijnhoven BP, Michael MZ, Watson DI. MicroRNAs and cancer. Br J Surg. 2007 Jan; 94(1): 23-30. (Pubitemid 46142727)
45. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffinembedded samples. RNA. 2007 Oct; 13(10): 1668-74. (Pubitemid 47481675)
46. Yang L, Belaguli N, Berger DH. MicroRNA and colorectal cancer. World J Surg. 2009 Apr; 33(4): 638-46.
47. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol. 2007 May 28; 13(20): 2883-8. (Pubitemid 47007908)